A precision medicine trial leveraging tissue and blood-based tumor genomics to optimize treatment in resected stage III and high-risk stage II colon cancer (CC) patients (pts): The SAGITTARIUS trial.

Authors: Clara O. Montagut, Stefano Tamberi, Francesco Leone, Michela Libertini, Francesca Negri, Alessandro Pastorino, Salvatore Siena, Elisabetta Fenocchio, Alessandra Gennari, Mario Mandala, Armando Santoro, Noelia Tarazona, Elena Elez, Andrea Sartore-Bianchi, Sebastian Stintzing, Susana Muñoz, Annarita Sibilio, Ylenia Silvestri, Luca Lazzari, Silvia Marsoni

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3647

Source: Full article


Abstract

TPS3647